Internal Medicine, Nephrology · Houston, TX
NPI
1609051853
Since 2008
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
6560 Fannin St Ste 1730
Houston, TX, 77030
Phone (713) 691-0107
Groups this clinician bills Medicare through
Medicare paid, 2024
$70.4M
37,657 services
Medicare patients, 2024
321
Average age 75
Drug cost, 2024
$444K
1,669 prescriptions
Company payments, 2025
$411
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rahul Pandey was code Q4275 (esano aca, per square centimeter), 33,098 times for 110 patients. In total Rahul Pandey billed 37,657 services in 33 codes, and Medicare paid $70.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q4275 Esano aca, per square centimeter | Office | 33,098 | 110 | $2,079.15 | $68.8M |
| 97610 Skin | Office | 1,181 | 86 | $330.90 | $391K |
| 15271 Skin and Soft Tissue Substitutes | Office | 758 | 116 | $121.14 | $92K |
| 99458 E&M - Miscellaneous | Office | 546 | 27 | $31.19 | $17K |
| 99232 Hospital E&M - Subsequent | Facility | 260 | 79 | $61.47 | $16K |
| 99457 E&M - Miscellaneous | Office | 253 | 28 | $35.24 | $8,915 |
| 99454 E&M - Miscellaneous | Office | 209 | 28 | $36.70 | $7,671 |
| 99214 Office E&M - Established | Office | 156 | 71 | $53.34 | $8,320 |
| 90960 ESRD Related Services (not dialysis) | Office | 149 | 21 | $274.34 | $41K |
| 99342 Home E&M - New and Established | Office | 89 | 89 | $58.77 | $5,231 |
| 11042 Debridement | Office | 62 | 62 | $100.52 | $6,233 |
| 99233 Hospital E&M - Subsequent | Facility | 49 | 15 | $92.67 | $4,541 |
| 99222 Hospital E&M - Initial | Facility | 45 | 39 | $98.88 | $4,450 |
| 99213 Office E&M - Established | Office | 40 | 24 | $37.53 | $1,501 |
| 99204 Office E&M - New | Office | 20 | 20 | $132.95 | $2,659 |
By year: 2022 $138K for 1,208 services; 2023 $146K for 1,853 services; 2024 $70.4M for 37,657 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rahul Pandey prescribed most often to Medicare patients was Furosemide, with 208 prescriptions and refills. In total Rahul Pandey wrote 1,669 Medicare prescriptions that cost $444K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Furosemide Generic | 208 | 592 | 87 | $1,017 |
| Paricalcitol Generic | 105 | 275 | 35 | $20K |
| Farxiga Dapagliflozin Propanediol | 87 | 219 | 40 | $116K |
| Amlodipine Besylate Generic | 79 | 223 | 37 | $297 |
| Carvedilol Generic | 74 | 202 | 36 | $468 |
| Sevelamer Carbonate Generic | 72 | 106 | 22 | $19K |
| Calcium Acetate Generic | 64 | 92 | 22 | $5,754 |
| Metolazone Generic | 59 | 159 | 28 | $2,099 |
| Hydralazine Hcl Generic | 52 | 151 | 29 | $757 |
| Nifedipine Er Nifedipine | 47 | 127 | 17 | $1,315 |
| Procrit Epoetin Alfa | 45 | 45 | 15 | $47K |
| Prosol Parenteral Amino Acid 20% No.1 | 44 | 44 | Under 11 | $3,595 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 39 | 87 | 29 | $370 |
| Xphozah Tenapanor Hcl | 37 | 37 | Under 11 | $103K |
| Potassium Chloride Generic | 34 | 76 | 17 | $793 |
Brand drugs: 364 claims; generic drugs: 1,305 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rahul Pandey $411 ($411 in general payments such as food, travel and fees) from 13 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $78.95.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 4 | $78.95 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $64.31 |
| Calliditas Therapeutics US Inc. | 3 | $55.87 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $53.49 |
| Ardelyx, Inc. ARDX | 2 | $50.5 |
| Apellis Pharmaceuticals, Inc. APLS | 1 | $27.14 |
| Amgen Inc. AMGN | 1 | $24.36 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $21.29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20.55 |
| OPKO Pharmaceuticals, LLC | 1 | $14.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.